{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T05:17:54Z","timestamp":1781759874204,"version":"3.54.5"},"reference-count":42,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T00:00:00Z","timestamp":1770163200000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The prevalence and role of frailty in preclinical Alzheimer\u2019s disease (AD) is unclear.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Cross-sectional analyses of pre-randomization data from the Anti-Amyloid Treatment in Asymptomatic AD (A4) study were analysed to derive two models of a frailty index (FI)\u2014full [FI-Full] and cognitive variables removed [FI-CVR]. The prevalence of frailty (FI\u2009&amp;gt;\u20090.25) according to amyloid status (A\u03b2+\/\u2212), and the association of frailty and cognition (determined by the Preclinical Alzheimer Cognitive Composite (PACC) score) and whether frailty moderates the relationship between amyloid status and cognition was assessed, adjusting for age, sex and education.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Four thousand four hundred eighty-six participants were included (mean age 71.3\u2009\u00b1\u20094.7\u00a0years, 30% participants A\u03b2+, 59% female). The prevalence of frailty in preclinical AD was 22% (or 44% when cognitive variables were removed from the FI). Using either FI model, in adjusted analyses, A\u03b2+ participants were more likely to be frail compared to A\u03b2\u2212 [FI-Full\u2014Odds ratio (OR) 1.43 95% confidence interval (CI) 1.20\u20131.71, P\u2009&amp;lt;\u2009.001; FI-CVR\u2014OR 1.21 95% CI 1.05\u20131.40, P\u2009&amp;lt;\u2009.008]. Frail participants had lower PACC scores compared to non-frail participants, on average (FI-Full\u2014PACC score \u22120.58 95% CI \u22120.76 to \u22120.40, P\u2009&amp;lt;\u2009.001; FI-CVR\u2014PACC score \u22120.26 95% CI \u22120.40 to \u22120.12, P\u2009&amp;lt;\u2009.001). Frailty did not influence the relationship between A\u03b2 status and cognition.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>In a cohort screened for a preclinical AD trial, elevated A\u03b2 levels were associated with frailty and frailty was associated with reduced cognitive performance independent of elevated A\u03b2 levels. These associations, and whether or not frailty is associated with longitudinal cognitive decline independent of A\u03b2 status, warrant further study.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ageing\/afaf378","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T12:30:57Z","timestamp":1768307457000},"source":"Crossref","is-referenced-by-count":1,"title":["Prevalence of frailty and its association with cognition in preclinical Alzheimer\u2019s disease: a cross-sectional analysis of baseline data from the A4 study"],"prefix":"10.1093","volume":"55","author":[{"given":"Andrew L H","family":"Huynh","sequence":"first","affiliation":[{"name":"Department of Geriatric Medicine, Austin Health , Heidelberg, Melbourne, Victoria ,","place":["Australia"]},{"name":"Department of Medicine, Austin Health, The University of Melbourne , Heidelberg, Melbourne, Victoria ,","place":["Australia"]},{"name":"The Florey Institute of Neuroscience and Mental Health , Parkville, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunran","family":"Wang","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute , Keck School of Medicine, University of Southern California, San Diego, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Austin Health , Heidelberg, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanka","family":"Amadoru","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Austin Health , Heidelberg, Melbourne, Victoria ,","place":["Australia"]},{"name":"Department of Medicine, Austin Health, The University of Melbourne , Heidelberg, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Wrigley","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Austin Health , Heidelberg, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Zisis","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health , Parkville, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Ernstrom","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute , Keck School of Medicine, University of Southern California, San Diego, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rema","family":"Raman","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute , Keck School of Medicine, University of Southern California, San Diego, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Aisen","sequence":"additional","affiliation":[{"name":"Alzheimer\u2019s Therapeutic Research Institute , Keck School of Medicine, University of Southern California, San Diego, CA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reisa A","family":"Sperling","sequence":"additional","affiliation":[{"name":"Department of Neurology, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Center for Alzheimer Research and Treatment , Department of Neurology, Brigham and Women's Hospital, Boston, MA,","place":["USA"]},{"name":"Harvard Medical School , Boston, MA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3072-7940","authenticated-orcid":false,"given":"Colin L","family":"Masters","sequence":"additional","affiliation":[{"name":"The Florey Institute of Neuroscience and Mental Health, The University of Melbourne , Parkville, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-9526","authenticated-orcid":false,"given":"David","family":"Ward","sequence":"additional","affiliation":[{"name":"Centre for Health Services Research , Faculty of Health, Medicine and Behavioural Sciences, The University of Queensland, Princess Alexandra Hospital, Woolloongabba, Queensland ,","place":["Australia"]},{"name":"Australian Frailty Network , The University of Queensland, Woolloongabba, Queensland ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A","family":"Yates","sequence":"additional","affiliation":[{"name":"Department of Geriatric Medicine, Austin Health , Heidelberg, Melbourne, Victoria ,","place":["Australia"]},{"name":"Department of Medicine, Austin Health, The University of Melbourne , Heidelberg, Melbourne, Victoria ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,1,22]]},"reference":[{"key":"2026020405471438000_ref1","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty consensus: a call to action","volume":"14","author":"Morley","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"2026020405471438000_ref2","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/S0140-6736(12)62167-9","article-title":"Frailty in elderly people","volume":"381","author":"Clegg","year":"2013","journal-title":"Lancet"},{"key":"2026020405471438000_ref3","doi-asserted-by":"publisher","first-page":"M146","DOI":"10.1093\/gerona\/56.3.m146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026020405471438000_ref4","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1093\/gerona\/gly197","article-title":"Validation of a claims-based frailty index against physical performance and adverse health outcomes in the health and retirement study","volume":"74","author":"Kim","year":"2019","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026020405471438000_ref5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1100\/tsw.2001.58","article-title":"Accumulation of deficits as a proxy measure of aging","volume":"1","author":"Mitnitski","year":"2001","journal-title":"Sci World J"},{"key":"2026020405471438000_ref6","doi-asserted-by":"publisher","first-page":"15746","DOI":"10.1038\/s41598-017-16104-y","article-title":"Frailty is an independent predictor of incident dementia: evidence from the English longitudinal study of ageing","volume":"7","author":"Rogers","year":"2017","journal-title":"Sci Rep"},{"key":"2026020405471438000_ref7","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1212\/WNL.0b013e318225c6bc","article-title":"Nontraditional risk factors combine to predict Alzheimer disease and dementia","volume":"77","author":"Song","year":"2011","journal-title":"Neurology"},{"key":"2026020405471438000_ref8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1001\/jamaneurol.2024.3774","article-title":"Frailty trajectories preceding dementia in the US and UK","volume":"82","author":"Ward","year":"2025","journal-title":"JAMA Neurol"},{"key":"2026020405471438000_ref9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1136\/jnnp-2020-324081","article-title":"Cumulative health deficits, APOE genotype, and risk for later-life mild cognitive impairment and dementia","volume":"92","author":"Ward","year":"2021","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2026020405471438000_ref10","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S1474-4422(18)30371-5","article-title":"Investigation of frailty as a moderator of the relationship between neuropathology and dementia in Alzheimer's disease: a cross-sectional analysis of data from the rush memory and aging project","volume":"18","author":"Wallace","year":"2019","journal-title":"The Lancet Neurology"},{"key":"2026020405471438000_ref11","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jalz.2016.02.002","article-title":"Preclinical Alzheimer's disease: definition, natural history, and diagnostic criteria","volume":"12","author":"Dubois","year":"2016","journal-title":"Alzheimers Dement"},{"key":"2026020405471438000_ref12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.neubiorev.2019.09.001","article-title":"Co-occurrence of cognitive impairment and physical frailty, and incidence of dementia: systematic review and meta-analysis","volume":"107","author":"Grande","year":"2019","journal-title":"Neurosci Biobehav Rev"},{"key":"2026020405471438000_ref13","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13195-023-01260-3","article-title":"Frailty in randomised controlled trials for dementia or mild cognitive impairment measured via the frailty index: prevalence and prediction of serious adverse events and attrition","volume":"15","author":"Wightman","year":"2023","journal-title":"Alzheimers Res Ther"},{"key":"2026020405471438000_ref14","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1056\/NEJMoa2305032","article-title":"Trial of Solanezumab in preclinical Alzheimer's disease","volume":"389","author":"Sperling","year":"2023","journal-title":"N Engl J Med"},{"key":"2026020405471438000_ref15","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors with elevated amyloid burden in clinically normal older individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurol"},{"key":"2026020405471438000_ref16","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.1212\/wnl.43.11.2412-a","article-title":"The clinical dementia rating (CDR): current version and scoring rules","volume":"43","author":"Morris","year":"1993","journal-title":"Neurology"},{"key":"2026020405471438000_ref17","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d: a practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"2026020405471438000_ref18","volume-title":"WMS-R: Wechsler Memory Scale-Revised","author":"Wechsler","year":"1987"},{"key":"2026020405471438000_ref19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1080\/09084282.2013.780172","article-title":"Development of alternate paragraphs for the logical memory subtest of the Wechsler memory scale-IV","volume":"21","author":"Morris","year":"2014","journal-title":"Appl Neuropsychol Adult"},{"key":"2026020405471438000_ref20","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s13195-021-00836-1","article-title":"Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach","volume":"13","author":"Royse","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"2026020405471438000_ref21","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1001\/jamaneurol.2014.803","article-title":"The preclinical Alzheimer cognitive composite: measuring amyloid-related decline","volume":"71","author":"Donohue","year":"2014","journal-title":"JAMA Neurol"},{"key":"2026020405471438000_ref22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1080\/13803395.2019.1593949","article-title":"Sensitivity of a preclinical Alzheimer's cognitive composite (PACC) to amyloid beta load in preclinical Alzheimer's disease","volume":"41","author":"Bransby","year":"2019","journal-title":"J Clin Exp Neuropsychol"},{"key":"2026020405471438000_ref23","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1016\/j.jalz.2017.01.018","article-title":"Early and late change on the preclinical Alzheimer's cognitive composite in clinically normal older individuals with elevated amyloid beta","volume":"13","author":"Mormino","year":"2017","journal-title":"Alzheimers Dement"},{"key":"2026020405471438000_ref24","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1017\/S1355617708080302","article-title":"Memory impairment, executive dysfunction, and intellectual decline in preclinical Alzheimer's disease","volume":"14","author":"Grober","year":"2008","journal-title":"J Int Neuropsychol Soc"},{"key":"2026020405471438000_ref25","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1037\/0735-7028.26.5.491","article-title":"Identification of malingered head injury on the Wechsler adult intelligence scale\u2014revised","volume":"26","author":"Mittenberg","year":"1995","journal-title":"Prof Psychol Res Pract"},{"key":"2026020405471438000_ref26","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1471-2318-8-24","article-title":"A standard procedure for creating a frailty index","volume":"8","author":"Searle","year":"2008","journal-title":"BMC Geriatr"},{"key":"2026020405471438000_ref27","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1093\/gerona\/62.7.738","article-title":"A comparison of two approaches to measuring frailty in elderly people","volume":"62","author":"Rockwood","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026020405471438000_ref28","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ageing\/afaa219","article-title":"Prevalence of frailty in 62 countries across the world: a systematic review and meta-analysis of population-level studies","volume":"50","author":"O'Caoimh","year":"2021","journal-title":"Age Ageing"},{"key":"2026020405471438000_ref29","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.exger.2019.05.010","article-title":"Geospatial modelling of the prevalence and changing distribution of frailty in Australia\u20132011 to 2027","volume":"123","author":"Taylor","year":"2019","journal-title":"Exp Gerontol"},{"key":"2026020405471438000_ref30","doi-asserted-by":"publisher","DOI":"10.1186\/s12877-017-0423-6","article-title":"Prevalence of frailty in Canadians 18-79 years old in the Canadian health measures survey","volume":"17","author":"Kehler","year":"2017","journal-title":"BMC Geriatr"},{"key":"2026020405471438000_ref31","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2020.104220","article-title":"National prevalence of frailty in the older Japanese population: findings from a nationally representative survey","volume":"91","author":"Murayama","year":"2020","journal-title":"Arch Gerontol Geriatr"},{"key":"2026020405471438000_ref32","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/gerona\/glv133","article-title":"Frailty in older adults: a nationally representative profile in the United States","volume":"70","author":"Bandeen-Roche","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"2026020405471438000_ref33","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1093\/gerona\/glz009","article-title":"Association between brain \u03b2-amyloid and frailty in older adults","volume":"74","author":"Maltais","year":"2019","journal-title":"The Journals of Gerontology: Series A"},{"key":"2026020405471438000_ref34","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1002\/alz.12748","article-title":"The AHEAD 3-45 study: design of a prevention trial for Alzheimer's disease","volume":"19","author":"Rafii","year":"2023","journal-title":"Alzheimers Dement"},{"key":"2026020405471438000_ref35","doi-asserted-by":"publisher","first-page":"e70662","DOI":"10.1002\/alz.70662","article-title":"Donanemab in preclinical Alzheimer's disease: screening and baseline data from TRAILBLAZER-ALZ 3","volume":"21","author":"Yaari","year":"2025","journal-title":"Alzheimers Dement"},{"key":"2026020405471438000_ref36","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2005.06.003","article-title":"Ways toward an early diagnosis in Alzheimer\u2019s disease: the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI)","volume":"1","author":"Mueller","year":"2005","journal-title":"Alzheimers Dement"},{"key":"2026020405471438000_ref37","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1017\/S1041610209009405","article-title":"The Australian imaging, biomarkers and lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease","volume":"21","author":"Ellis","year":"2009","journal-title":"Int Psychogeriatr"},{"key":"2026020405471438000_ref38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm7070169","article-title":"Physical frailty and amyloid-beta deposits in the brains of older adults with cognitive frailty","volume":"7","author":"Yoon","year":"2018","journal-title":"J Clin Med"},{"key":"2026020405471438000_ref39","doi-asserted-by":"publisher","first-page":"1569","DOI":"10.1093\/ageing\/afab102","article-title":"Frailty\u2014a risk factor of global and domain-specific cognitive decline among a nationally representative sample of community-dwelling older adult US Medicare beneficiaries","volume":"50","author":"Chu","year":"2021","journal-title":"Age Ageing"},{"key":"2026020405471438000_ref40","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.jad.2024.03.049","article-title":"Dynamic associations between frailty and cognition over 4 years: a population-based study on adults aged\u2265 50 from 12 European countries","volume":"354","author":"Maio","year":"2024","journal-title":"J Affect Disord"},{"key":"2026020405471438000_ref41","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1474-4422(23)00128-X","article-title":"The complex pathway between amyloid \u03b2 and cognition: implications for therapy","volume":"22","author":"Jagust","year":"2023","journal-title":"The Lancet Neurology"},{"key":"2026020405471438000_ref42","doi-asserted-by":"publisher","first-page":"41","DOI":"10.14283\/jpad.2020.60","article-title":"Prospective associations between plasma amyloid-beta 42\/40 and frailty in community-dwelling older adults","volume":"8","author":"Lu","year":"2021","journal-title":"J Prev Alzheimers Dis"}],"container-title":["Age and Ageing"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/1\/afaf378\/66538294\/afaf378.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ageing\/article-pdf\/55\/1\/afaf378\/66538294\/afaf378.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T10:47:18Z","timestamp":1770202038000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ageing\/article\/doi\/10.1093\/ageing\/afaf378\/8437974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/ageing\/afaf378","relation":{},"ISSN":["0002-0729","1468-2834"],"issn-type":[{"value":"0002-0729","type":"print"},{"value":"1468-2834","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"afaf378"}}